Why the FDA didn’t approve Genzyme’s multiple sclerosis drug, Lemtrada

Genzyme’s multiple sclerosis drug, Lemtrada, was rejected in the U.S. based on the same trials that regulators in Canada, Europe and Australia deemed sufficient to approve it...